Sunday, January 26, 2020

Enrollment Nearly Complete for Phase 2 Clinical Trials Testing ELX-02 in CF Patients Jan 23, 2020 07:00 am | Marisa Wexler MS

https://cysticfibrosisnewstoday.com/2020/01/23/enrollment-nearly-complete-for-phase-2-clinical-trials-testing-elx-02-in-cf-patients/?utm_source=Cystic+Fibrosis&utm_campaign=5ce7c74247-RSS_MONDAY_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b075749015-5ce7c74247-72020733
Cystic Fibrosis News Today

Enrollment Nearly Complete for Phase 2 Clinical Trials Testing ELX-02 in CF Patients

Jan 23, 2020 07:00 am | Marisa Wexler MS

CRISPR-Cas9 gene therapy, CF
Enrollment is nearing completion for two Phase 2 clinical trials testing the experimental treatment ELX-02 in people with cystic fibrosis (CF), according to Eloxx Pharmaceuticals, the company developing ELX-02. “We expect full enrollment to be achieved during the first quarter of 2020, and to report topline results during the first half of 2020,” Eloxx stated […]
The post Enrollment Nearly Complete for Phase 2 Clinical Trials Testing ELX-02 in CF Patients appeared first on Cystic Fibrosis News Today.
Read More

No comments:

Post a Comment